{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:47:51Z","timestamp":1792853271528,"version":"4.5.0"},"reference-count":178,"publisher":"Wiley","issue":"11-12","license":[{"start":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T00:00:00Z","timestamp":1139875200000},"content-version":"vor","delay-in-days":105,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:p>Allogeneic hematopoietic stem cell transplantation (ASCT) is a well\u2010established therapy for leukemias and other immunohematopoietic disorders. In more recent years, bone marrow as stem cell source has been replaced by peripheral blood stem cells, which results in faster engraftment. Cord blood grafts are increasingly used. Conditioning prior to transplant may be myeloablative or nonmyeloablative. The latter is used preferentially in patients with high age or organ impairment. Isolation in the hospital during posttransplant pancytopenia has been challenged by promising results using home care. PCR diagnosis and new antifungal and antiviral treatment have reduced morbidity and mortality. The major threat to a successful outcome after ASCT is leukemic relapse. PCR techniques to detect recipient cells in the leukemic cell lineage or minimal residual disease enable early detection of leukemic cells. Donor lymphocyte infusions have an antileukemic effect. ASCT has shown an antitumor effect in metastatic cancers from breast, kidney, colon, ovaries, prostate and pancreas. Mesenchymal stem cells may be derived from bone marrow and have the capacity to differentiate into several mesenchymal tissues, such as bone, cartilage and fat. They seem to escape the immune system and have immunomodulatory effects <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo.<\/jats:italic> To conclude, ASCT is a potent immunotherapy.<\/jats:p>","DOI":"10.1111\/j.1600-0463.2005.apm_336.x","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T13:59:54Z","timestamp":1139925594000},"page":"813-830","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives"],"prefix":"10.1111","volume":"113","author":[{"given":"OLLE","family":"RINGD\u00c9N","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KATARINA","family":"LE BLANC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,2,14]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195709122571102"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/1801430a0"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(68)92673-1"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(68)92672-X"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V49.4.511.511"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.9.1340"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.2.572"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-3-199602010-00005"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V48.6.817.817"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198410000-00001"},{"key":"e_1_2_5_12_2","first-page":"1455","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Peters C","year":"2004"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199102000-00034"},{"key":"e_1_2_5_14_2","first-page":"371","article-title":"Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study","volume":"12","author":"Hows JM","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4455.bloodjournal87104455"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02990940"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2003.10.001"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V85.6.1666.bloodjournal8561666","article-title":"Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (G\u2010CSF)","volume":"85","author":"Schmitz N","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.7.2794.bloodjournal8872794"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.12.049"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.12.4705"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V94.2.455","article-title":"Peripheral blood stem cell (PBSC) transplantation from unrelated donors: a comparison with marrow transplantation","volume":"94","author":"Ringd\u00e9n O","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1000"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.189"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708073370602"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.795.795"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-4125"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349409006245"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1983.tb01069.x"},{"key":"e_1_2_5_30_2","first-page":"113","volume-title":"Progress in Bone Marrow Transplantation","author":"Santos WG","year":"1987"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V70.5.1382.1382"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","article-title":"Increased risk of chronic graft\u2010versus\u2010host disease, obstructive bronchiolitis and alopecia using busulfan compared to total body irradiation: long\u2010term results of a randomized trial in allogeneic marrow recipients with leukemia. The Nordic Bone Marrow Transplantation Group","volume":"93","author":"Ringd\u00e9n O","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3569"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V84.7.2144.2144","article-title":"Busulphan bioavailability","volume":"84","author":"Hassan M","year":"1994","journal-title":"Blood"},{"key":"e_1_2_5_35_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood.V70.1.116.116","article-title":"Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin","volume":"70","author":"Storb R","year":"1987","journal-title":"Blood"},{"key":"e_1_2_5_36_2","first-page":"193","article-title":"Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children","volume":"1","author":"Shaw PJ","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_37_2","article-title":"Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single\u2010center","author":"Ringd\u00e9n O","year":"2005","journal-title":"Transplantation"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.9.1867.1867"},{"issue":"2","key":"e_1_2_5_39_2","first-page":"6","article-title":"Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia","volume":"7","author":"Buckner CD","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_40_2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Non myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non\u2010malignant hematologic diseases","volume":"91","author":"Slavin S","year":"1998","journal-title":"Blood"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0571"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.12.4531"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.9.3234"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703811"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.1999.v5.pm10465099"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3390"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1340"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000129809.09718.7E"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0545"},{"key":"e_1_2_5_50_2","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","article-title":"T\u2010cell depletion of HLA\u2010identical transplants in leukemia","volume":"78","author":"Marmont AM","year":"1990","journal-title":"Blood"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198901263200401"},{"issue":"3","key":"e_1_2_5_52_2","first-page":"S50","article-title":"The role of hematopoietic growth factor in the treatment of graft failure","volume":"12","author":"Nemunaitis J","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_53_2","first-page":"163","article-title":"Transfusion problems associated with transplantation","volume":"18","author":"Storb R","year":"1981","journal-title":"Seminars in Hematology"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01698131"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-6-893"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701238"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0801"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705096"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530130404"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2005.01.009"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.06.102"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701996"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704108"},{"key":"e_1_2_5_64_2","first-page":"397","article-title":"Reduced blood transfusion requirements after allogeneic bone marrow transplantation \u2013 results of a randomised, double\u2010blind study with high dose erythropoietin","volume":"13","author":"Klaesson S","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197003000-00007"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198611000-00001"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.6.1729.1729"},{"key":"e_1_2_5_68_2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.V81.4.1094.1094","article-title":"Methotrexate, cyclosporine or both to prevent graft\u2010versus\u2010host disease after HLA\u2010identical sibling bone marrow transplants for early leukemia?","volume":"81","author":"Ringd\u00e9n O","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_69_2","first-page":"41","article-title":"A randomized trial comparing the use of cyclosporin and methotrexate for graft\u2010versus\u2010host disease prophylaxis in bone marrow transplant recipients with haematologic malignancies","volume":"1","author":"Ringd\u00e9n O","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-1-12"},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199009133231103"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-6-806"},{"key":"e_1_2_5_73_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft\u2010versus\u2010leukemia reactions following bone marrow transplantation in humans","volume":"75","author":"Horowitz MM","year":"1990","journal-title":"Blood"},{"issue":"1","key":"e_1_2_5_74_2","first-page":"22","article-title":"Prevention and therapy of graft\u2010versus\u2010host disease. Report from a workshop","volume":"10","author":"Ringd\u00e9n O","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3634.bloodjournal8893634"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.8.3514.bloodjournal8783514"},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0489"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703374"},{"key":"e_1_2_5_79_2","first-page":"619","article-title":"Similar incidence of graft\u2010versus\u2010host disease using HLA\u2010A, \u2010B and \u2010DR identical unrelated bone marrow donors as with HLA\u2010identical siblings","volume":"15","author":"Ringd\u00e9n O","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_80_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.10.2942"},{"key":"e_1_2_5_81_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","article-title":"A dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem\u2010cell transplantation","volume":"78","author":"Remberger M","year":"2004","journal-title":"Transplantation"},{"key":"e_1_2_5_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1993.tb00597.x"},{"key":"e_1_2_5_83_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2001.150301.x"},{"key":"e_1_2_5_84_2","volume-title":"Graft\u2010versus\u2010host disease","author":"Van Bekkum DW","year":"1985"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1985.tb01160.x"},{"key":"e_1_2_5_86_2","first-page":"525","volume-title":"Graft vs Host Disease","author":"Ringd\u00e9n O","year":"1996"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(99)70011-X"},{"key":"e_1_2_5_88_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V57.2.267.267"},{"key":"e_1_2_5_89_2","first-page":"545","article-title":"Chronic cutaneous graft\u2010versus\u2010host disease in man","volume":"91","author":"Shulman HM","year":"1978","journal-title":"Am J Path"},{"key":"e_1_2_5_90_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.2.406"},{"key":"e_1_2_5_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701423"},{"key":"e_1_2_5_92_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-4-461"},{"key":"e_1_2_5_93_2","first-page":"1062","article-title":"An analysis of factors predisposing for chronic graft\u2010versus\u2010host disease","volume":"13","author":"Ringd\u00e9n O","year":"1985","journal-title":"Exp Hematol"},{"key":"e_1_2_5_94_2","first-page":"2603","article-title":"Anti\u2010CD20 monoclonal antibody treatment in 6 patients with therapy\u2010refractory chronic graft\u2010versus\u2010host disease","volume":"104","author":"Canninga\u2010van Dijk MR","year":"2004","journal-title":"Transplantation"},{"key":"e_1_2_5_95_2","first-page":"525","volume-title":"Clinical approach to infection in the compromised host","author":"Meyers JD","year":"1988"},{"key":"e_1_2_5_96_2","first-page":"3530","article-title":"Risk factors for septicaemia during aplastic period after allogeneic bone marrow transplantation","volume":"27","author":"Sparrelid E","year":"1995","journal-title":"Transplant Proc"},{"key":"e_1_2_5_97_2","first-page":"635","article-title":"Variables predicting deep fungal infections in bone marrow transplant recipients","volume":"4","author":"Tollemar J","year":"1989","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"e_1_2_5_98_2","first-page":"10","article-title":"Fungal infections in bone marrow transplant patients","volume":"17","author":"Meyers JD","year":"1990","journal-title":"Semin Oncol"},{"key":"e_1_2_5_99_2","first-page":"167","article-title":"Liposomal amphotericin B (AmBisome) treatment in solid organ and bone marrow transplant recipients","volume":"4","author":"Tollemar J","year":"1990","journal-title":"Efficacy and safety evaluation. Clin Transplant"},{"key":"e_1_2_5_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/28.suppl_B.73"},{"key":"e_1_2_5_101_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1996.tb00123.x"},{"key":"e_1_2_5_102_2","first-page":"338","article-title":"Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus\u2010specific gene","volume":"108","author":"Buchman TH","year":"1990","journal-title":"Surgery"},{"key":"e_1_2_5_103_2","doi-asserted-by":"publisher","DOI":"10.1086\/315435"},{"key":"e_1_2_5_104_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00451.x"},{"key":"e_1_2_5_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/153.3.478"},{"key":"e_1_2_5_106_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198504000-00008"},{"key":"e_1_2_5_107_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198703000-00015"},{"key":"e_1_2_5_108_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548609032328"},{"key":"e_1_2_5_109_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-10-777"},{"key":"e_1_2_5_110_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.3.373"},{"key":"e_1_2_5_111_2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V77.5.1104.1104","article-title":"Early occurrence of HCMV infection after BMT as demonstrated by the PCR technique","volume":"77","author":"Einsele H","year":"1991","journal-title":"Blood"},{"key":"e_1_2_5_112_2","first-page":"583","article-title":"Use of a semi\u2010quantitative PCR for cytomegalovirus DNA as a basis for pre\u2010emptive antiviral therapy in allogeneic bone marrow transplant patients","volume":"17","author":"Ljungman P","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_113_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199811270-00012"},{"key":"e_1_2_5_114_2","first-page":"415","volume-title":"Clinical Bone Marrow Transplantation","author":"Giralt S","year":"1994"},{"key":"e_1_2_5_115_2","first-page":"113","article-title":"Methotrexate combined with cyclosporine A decreases graft\u2010versus\u2010host disease, but increases leukemic relapse compared to monotherapy","volume":"7","author":"Aschan J","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_116_2","first-page":"221","article-title":"Prevention of graft\u2010versus\u2010host disease with T cell depletion or cyclosporin and methotrexate","volume":"7","author":"Ringd\u00e9n O","year":"1991","journal-title":"A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant"},{"key":"e_1_2_5_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)91037-9"},{"key":"e_1_2_5_118_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198106183042507"},{"key":"e_1_2_5_119_2","first-page":"921","article-title":"Graft\u2010versus\u2010leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"18","author":"Ringd\u00e9n O","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_120_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609045715"},{"key":"e_1_2_5_121_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02493.x"},{"key":"e_1_2_5_122_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.7.1423.1423"},{"key":"e_1_2_5_123_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701954"},{"key":"e_1_2_5_124_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.12.2462.2462"},{"key":"e_1_2_5_125_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041"},{"key":"e_1_2_5_126_2","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2001.v7.pm11215696"},{"key":"e_1_2_5_127_2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft\u2010versus\u2010leukemia responses from graft\u2010versus\u2010leukemia disease","volume":"86","author":"MacKinnon S","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_128_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.1.67"},{"key":"e_1_2_5_129_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.11.2269"},{"key":"e_1_2_5_130_2","first-page":"1302","article-title":"Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review","volume":"7","author":"Potter MN","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_5_131_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402311"},{"key":"e_1_2_5_132_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.11.3409.3409"},{"key":"e_1_2_5_133_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.11.2504.2504"},{"key":"e_1_2_5_134_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402311"},{"key":"e_1_2_5_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92508-7"},{"key":"e_1_2_5_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91490-6"},{"key":"e_1_2_5_137_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00873.x"},{"key":"e_1_2_5_138_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.11.4072"},{"key":"e_1_2_5_139_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1982"},{"key":"e_1_2_5_140_2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V51.6.1087.1087","article-title":"Does graft\u2010versus\u2010host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation of 56 long\u2010term survivors","volume":"51","author":"Noel DR","year":"1978","journal-title":"Blood"},{"key":"e_1_2_5_141_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood.V69.2.369.369","article-title":"The kinetics of immune reconstitution after human marrow transplantation","volume":"69","author":"Lum LG","year":"1987","journal-title":"Blood"},{"key":"e_1_2_5_142_2","first-page":"317","article-title":"Immunological recovery after bone marrow transplantation: role of age, graft\u2010versus\u2010host disease, prednisolone treatment and infections","volume":"1","author":"Paulin T","year":"1987","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_143_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702858"},{"key":"e_1_2_5_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02293-5"},{"key":"e_1_2_5_145_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3493"},{"key":"e_1_2_5_146_2","first-page":"387","article-title":"B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?","volume":"12","author":"Storek J","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_147_2","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.123.6.2729","article-title":"B cell function in human marrow transplant recipients assessed by direct and indirect hemolysis\u2010in\u2010gel assays","volume":"123","author":"Ringd\u00e9n O","year":"1979","journal-title":"J Immunol"},{"key":"e_1_2_5_148_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2005.01528.x"},{"key":"e_1_2_5_149_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2671"},{"key":"e_1_2_5_150_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<181::AID-RMV200>3.0.CO;2-W"},{"key":"e_1_2_5_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91150-2"},{"key":"e_1_2_5_152_2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V95.3.807.003k24_807_814","article-title":"Epstein\u2010Barr virus (EBV) load in bone marrow transplant recipients at risk to develop post\u2010transplant lymphoproliferative disease: prophylactic infusion of EBV\u2010specific cytotoxic T cells","volume":"95","author":"Gustafsson \u00c5","year":"2000","journal-title":"Blood"},{"key":"e_1_2_5_153_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199007000-00001"},{"key":"e_1_2_5_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09413-8"},{"key":"e_1_2_5_155_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0393"},{"key":"e_1_2_5_156_2","first-page":"1177","volume-title":"Allogeneic hematopoietic cell transplantation for solid tumors. Thomas' Hematopoietic Cell Transplantation","author":"Childs RW","year":"2004"},{"key":"e_1_2_5_157_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.4.1501.bloodjournal8841501"},{"key":"e_1_2_5_158_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.986"},{"key":"e_1_2_5_159_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.2044"},{"key":"e_1_2_5_160_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703287"},{"key":"e_1_2_5_161_2","unstructured":"BarkholtL BregniM RembergerM PeccatoriJ BlaiseD MassenkielG et al.The European experience of allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma. Submitted."},{"key":"e_1_2_5_162_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000058515.02300.5E"},{"key":"e_1_2_5_163_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66989-9"},{"key":"e_1_2_5_164_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-196803000-00009"},{"key":"e_1_2_5_165_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.01.005"},{"key":"e_1_2_5_166_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5411.143"},{"key":"e_1_2_5_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(92)90363-2"},{"key":"e_1_2_5_168_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(03)00110-3"},{"key":"e_1_2_5_169_2","first-page":"324","article-title":"Stromal cell modulation of the immune system","volume":"3","author":"McIntosh K","year":"2000","journal-title":"Graft"},{"key":"e_1_2_5_170_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01176.x"},{"key":"e_1_2_5_171_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000045055.63901.A9"},{"key":"e_1_2_5_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.12.013"},{"key":"e_1_2_5_173_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000082540.43730.80"},{"key":"e_1_2_5_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(01)00769-X"},{"key":"e_1_2_5_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16104-7"},{"key":"e_1_2_5_176_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1227"},{"key":"e_1_2_5_177_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.132252399"},{"key":"e_1_2_5_178_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000159029.48678.93"},{"key":"e_1_2_5_179_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.2.307"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0463.2005.apm_336.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0463.2005.apm_336.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T11:40:27Z","timestamp":1693395627000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0463.2005.apm_336.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":178,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1111\/j.1600-0463.2005.apm_336.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0463.2005.apm_336.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"2006-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}